Morgan Crucible/£MGAM
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Morgan Crucible
Morgan Advanced Materials plc, operating under the ticker MGAM, is a UK-based company renowned for its production of advanced carbon and ceramic materials. The company specializes in engineering high-performance materials utilized in various industrial sectors, including healthcare, electronics, and transportation. Founded in 1856, Morgan Advanced Materials has expanded its influence globally, focusing on delivering tailored solutions that address specific material challenges faced by their diverse client base.
Ticker
£MGAM
Sector
Primary listing
LSE
Employees
8,479
Headquarters
Morgan Crucible Metrics
BasicAdvanced
£553M
20.24
£0.10
1.07
£0.12
6.15%
Price and volume
Market cap
£553M
Beta
1.07
52-week high
£2.82
52-week low
£1.67
Average daily volume
510K
Dividend rate
£0.12
Financial strength
Current ratio
1.742
Quick ratio
1.093
Long term debt to equity
104.969
Total debt to equity
108.206
Dividend payout ratio (TTM)
123.66%
Interest coverage (TTM)
4.85%
Profitability
EBITDA (TTM)
146.8
Gross margin (TTM)
10.95%
Net profit margin (TTM)
2.66%
Operating margin (TTM)
10.80%
Effective tax rate (TTM)
37.91%
Revenue per employee (TTM)
£120,000
Management effectiveness
Return on assets (TTM)
6.84%
Return on equity (TTM)
9.34%
Valuation
Price to earnings (TTM)
20.238
Price to revenue (TTM)
0.534
Price to book
1.76
Price to tangible book (TTM)
3.91
Price to free cash flow (TTM)
20.697
Free cash flow yield (TTM)
4.83%
Free cash flow per share (TTM)
0.096
Dividend yield (TTM)
6.15%
Growth
Revenue change (TTM)
-7.30%
Earnings per share change (TTM)
-59.69%
3-year revenue growth (CAGR)
1.01%
10-year revenue growth (CAGR)
1.09%
3-year earnings per share growth (CAGR)
-29.17%
10-year earnings per share growth (CAGR)
5.77%
3-year dividend per share growth (CAGR)
2.89%
10-year dividend per share growth (CAGR)
1.04%
What the Analysts think about Morgan Crucible
Analyst ratings (Buy, Hold, Sell) for Morgan Crucible stock.
Bulls say / Bears say
Morgan’s simplification programme is on track to achieve £22 million in annualised savings by 2025 (up from £10 million) at an exceptional cost of £45 million, demonstrating strong operational efficiency and self-help measures (Morningstar).
Sales in Q1 2025 declined just 3.5% organically, in line with guidance, and the company expects minimal tariff impact due to its predominantly localised manufacturing footprint, highlighting resilience in a challenging environment (Alliance News).
The board has launched a £40 million share buy-back programme, underscoring management’s confidence in the balance sheet and commitment to returning capital to shareholders amid near-term market weakness (DirectorsTalk Interviews)
Adjusted revenue for H1 2025 fell 8.7% year-over-year to £522.6 million, with an organic constant-currency decline of 5.8% and adjusted operating profit down 18.7%, compressing margins by 140 basis points to 11.1% (Nasdaq).
Shares plunged as much as 25% after Morgan warned that full-year adjusted operating profit would be at the lower end of consensus (£115.6 million–£126.3 million) and that no second-half recovery is expected, underscoring deep end-market uncertainty (Reuters via TradingView).
Citigroup cut its price target on MGAM stock from 265 pence to 240 pence despite maintaining a Buy rating, reflecting analyst concerns over limited upside and persistent demand headwinds (MarketBeat)
Data summarised monthly by Lightyear AI. Last updated on 2 Oct 2025.
Morgan Crucible Financial Performance
Revenues and expenses
Morgan Crucible Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Morgan Crucible stock?
Morgan Crucible (MGAM) has a market cap of £553M as of October 21, 2025.
What is the P/E ratio for Morgan Crucible stock?
The price to earnings (P/E) ratio for Morgan Crucible (MGAM) stock is 20.24 as of October 21, 2025.
Does Morgan Crucible stock pay dividends?
Yes, the Morgan Crucible (MGAM) stock pays dividends to shareholders. As of October 21, 2025, the dividend rate is £0.122 and the yield is 6.15%. Morgan Crucible has a payout ratio of 123.66% on a trailing twelve-month basis.
When is the next Morgan Crucible dividend payment date?
The next Morgan Crucible (MGAM) dividend payment is scheduled for November 17, 2025.
What is the beta indicator for Morgan Crucible?
Morgan Crucible (MGAM) has a beta rating of 1.07. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.